Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen Chanock

Showing results (201-210 of 299) with videos related to

Pageof 30
Sort By:
Cancer Research|May 24, 2014
Telomere length in white blood cell DNA and lung cancer: a pooled analysis of three prospective cohortsWei Jie Seow, Richard M Cawthon, Mark P Purdue, et al.
HGG Advances|January 20, 2022
Comparison of somatic mutation landscapes in Chinese versus European breast cancer patientsBin Zhu, Lijin Joo, Tongwu Zhang, et al.
Carcinogenesis|October 4, 2011
Breast cancer susceptibility polymorphisms and endometrial cancer risk: a Collaborative Endometrial Cancer StudyCatherine S Healey, Shahana Ahmed, , et al.
American Journal of Epidemiology|November 30, 2012
Association of type 2 diabetes susceptibility variants with advanced prostate cancer risk in the Breast and Prostate Cancer Cohort ConsortiumMitchell J Machiela, Sara Lindström, Naomi E Allen, et al.
The New England Journal of Medicine|December 3, 2025
Noninferiority of One HPV Vaccine Dose to Two DosesAimée R Kreimer, Carolina Porras, Danping Liu, et al.
Human Molecular Genetics|July 31, 2018
Combining common genetic variants and non-genetic risk factors to predict risk of cutaneous melanomaFangyi Gu, Ting-Huei Chen, Ruth M Pfeiffer, et al.
American Journal of Human Genetics|May 5, 2018
A Mixed-Effects Model for Powerful Association Tests in Integrative Functional GenomicsYu-Ru Su, Chongzhi Di, Stephanie Bien, et al.
Nature Communications|April 29, 2024
Identifying therapeutic targets for cancer among 2074 circulating proteins and risk of nine cancersKarl Smith-Byrne, Åsa Hedman, Marios Dimitriou, et al.
Vaccine|December 3, 2021
Rationale and design of a double-blind randomized non-inferiority clinical trial to evaluate one or two doses of vaccine against human papillomavirus including an epidemiologic survey to estimate vaccine efficacy: The Costa Rica ESCUDDO trialCarolina Porras, Joshua N Sampson, Rolando Herrero, et al.
Oral Oncology|June 6, 2020
Summary from an international cancer seminar focused on human papillomavirus (HPV)-positive oropharynx cancer, convened by scientists at IARC and NCIAimée R Kreimer, Anil K Chaturvedi, Laia Alemany, et al.
Pageof 30

Showing results (201-210 of 299) with videos related to

Sort By:
Pageof 30
Cancer Research|May 24, 2014
Telomere length in white blood cell DNA and lung cancer: a pooled analysis of three prospective cohortsWei Jie Seow, Richard M Cawthon, Mark P Purdue, et al.
HGG Advances|January 20, 2022
Comparison of somatic mutation landscapes in Chinese versus European breast cancer patientsBin Zhu, Lijin Joo, Tongwu Zhang, et al.
Carcinogenesis|October 4, 2011
Breast cancer susceptibility polymorphisms and endometrial cancer risk: a Collaborative Endometrial Cancer StudyCatherine S Healey, Shahana Ahmed, , et al.
American Journal of Epidemiology|November 30, 2012
Association of type 2 diabetes susceptibility variants with advanced prostate cancer risk in the Breast and Prostate Cancer Cohort ConsortiumMitchell J Machiela, Sara Lindström, Naomi E Allen, et al.
The New England Journal of Medicine|December 3, 2025
Noninferiority of One HPV Vaccine Dose to Two DosesAimée R Kreimer, Carolina Porras, Danping Liu, et al.
Human Molecular Genetics|July 31, 2018
Combining common genetic variants and non-genetic risk factors to predict risk of cutaneous melanomaFangyi Gu, Ting-Huei Chen, Ruth M Pfeiffer, et al.
American Journal of Human Genetics|May 5, 2018
A Mixed-Effects Model for Powerful Association Tests in Integrative Functional GenomicsYu-Ru Su, Chongzhi Di, Stephanie Bien, et al.
Nature Communications|April 29, 2024
Identifying therapeutic targets for cancer among 2074 circulating proteins and risk of nine cancersKarl Smith-Byrne, Åsa Hedman, Marios Dimitriou, et al.
Vaccine|December 3, 2021
Rationale and design of a double-blind randomized non-inferiority clinical trial to evaluate one or two doses of vaccine against human papillomavirus including an epidemiologic survey to estimate vaccine efficacy: The Costa Rica ESCUDDO trialCarolina Porras, Joshua N Sampson, Rolando Herrero, et al.
Oral Oncology|June 6, 2020
Summary from an international cancer seminar focused on human papillomavirus (HPV)-positive oropharynx cancer, convened by scientists at IARC and NCIAimée R Kreimer, Anil K Chaturvedi, Laia Alemany, et al.
Pageof 30